Cargando…

Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH

BACKGROUND: Though outcome models have been proposed previously, it is unknown whether cutoffs in clinical pregnancy and live birth rates at all ages are able to classify in vitro fertilization (IVF) patients into good-, intermediate- and poor prognosis. METHODS: We here in 3 infertile patient cohor...

Descripción completa

Detalles Bibliográficos
Autores principales: Gleicher, Norbert, Kushnir, Vitaly A., Sen, Aritro, Darmon, Sarah K., Weghofer, Andrea, Wu, Yan-Guang, Wang, Qi, Zhang, Lin, Albertini, David F., Barad, David H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901433/
https://www.ncbi.nlm.nih.gov/pubmed/27286817
http://dx.doi.org/10.1186/s12967-016-0924-7
_version_ 1782436804233789440
author Gleicher, Norbert
Kushnir, Vitaly A.
Sen, Aritro
Darmon, Sarah K.
Weghofer, Andrea
Wu, Yan-Guang
Wang, Qi
Zhang, Lin
Albertini, David F.
Barad, David H.
author_facet Gleicher, Norbert
Kushnir, Vitaly A.
Sen, Aritro
Darmon, Sarah K.
Weghofer, Andrea
Wu, Yan-Guang
Wang, Qi
Zhang, Lin
Albertini, David F.
Barad, David H.
author_sort Gleicher, Norbert
collection PubMed
description BACKGROUND: Though outcome models have been proposed previously, it is unknown whether cutoffs in clinical pregnancy and live birth rates at all ages are able to classify in vitro fertilization (IVF) patients into good-, intermediate- and poor prognosis. METHODS: We here in 3 infertile patient cohorts, involving 1247, 1514 and 632 women, built logistic regression models based on 3 functional ovarian reserve (FOR) parameters, including (1) number of good quality embryos, (2) follicle stimulating hormone (FSH, mIU/mL) and (3) anti-Müllerian hormone (AMH, ng/mL), determining whether clinical pregnancy and live birth rates can discriminate between good, intermediate and poor prognosis patients. RESULTS: All models, indeed, allowed at all ages for separation by prognosis, though cut offs changed with age. In the embryo model, increasing embryo production resulted in linear improvement of IVF outcomes despite transfer of similar embryo numbers; in the FSH model outcomes and FSH levels related inversely, while the association of AMH followed a bell-shaped polynomial pattern, demonstrating “best” outcomes at mid-ranges. All 3 models demonstrated increasingly poor outcomes with advancing ages, though “best” AMH even above age 43 was still associated with unexpectedly good pregnancy and delivery outcomes. Excessively high AMH, in contrast, was at all ages associated with spiking miscarriage rates. CONCLUSIONS: At varying peripheral serum concentrations, AMH, thus, demonstrates hithero unknown and contradictory effects on IVF outcomes, deserving at different concentrations investigation as a potential therapeutic agent, with pregnancy-supporting and pregnancy-interrupting properties. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-016-0924-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4901433
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49014332016-06-11 Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH Gleicher, Norbert Kushnir, Vitaly A. Sen, Aritro Darmon, Sarah K. Weghofer, Andrea Wu, Yan-Guang Wang, Qi Zhang, Lin Albertini, David F. Barad, David H. J Transl Med Research BACKGROUND: Though outcome models have been proposed previously, it is unknown whether cutoffs in clinical pregnancy and live birth rates at all ages are able to classify in vitro fertilization (IVF) patients into good-, intermediate- and poor prognosis. METHODS: We here in 3 infertile patient cohorts, involving 1247, 1514 and 632 women, built logistic regression models based on 3 functional ovarian reserve (FOR) parameters, including (1) number of good quality embryos, (2) follicle stimulating hormone (FSH, mIU/mL) and (3) anti-Müllerian hormone (AMH, ng/mL), determining whether clinical pregnancy and live birth rates can discriminate between good, intermediate and poor prognosis patients. RESULTS: All models, indeed, allowed at all ages for separation by prognosis, though cut offs changed with age. In the embryo model, increasing embryo production resulted in linear improvement of IVF outcomes despite transfer of similar embryo numbers; in the FSH model outcomes and FSH levels related inversely, while the association of AMH followed a bell-shaped polynomial pattern, demonstrating “best” outcomes at mid-ranges. All 3 models demonstrated increasingly poor outcomes with advancing ages, though “best” AMH even above age 43 was still associated with unexpectedly good pregnancy and delivery outcomes. Excessively high AMH, in contrast, was at all ages associated with spiking miscarriage rates. CONCLUSIONS: At varying peripheral serum concentrations, AMH, thus, demonstrates hithero unknown and contradictory effects on IVF outcomes, deserving at different concentrations investigation as a potential therapeutic agent, with pregnancy-supporting and pregnancy-interrupting properties. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-016-0924-7) contains supplementary material, which is available to authorized users. BioMed Central 2016-06-10 /pmc/articles/PMC4901433/ /pubmed/27286817 http://dx.doi.org/10.1186/s12967-016-0924-7 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Gleicher, Norbert
Kushnir, Vitaly A.
Sen, Aritro
Darmon, Sarah K.
Weghofer, Andrea
Wu, Yan-Guang
Wang, Qi
Zhang, Lin
Albertini, David F.
Barad, David H.
Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH
title Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH
title_full Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH
title_fullStr Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH
title_full_unstemmed Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH
title_short Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH
title_sort definition by fsh, amh and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown ivf outcome-determining factor associated with amh
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901433/
https://www.ncbi.nlm.nih.gov/pubmed/27286817
http://dx.doi.org/10.1186/s12967-016-0924-7
work_keys_str_mv AT gleichernorbert definitionbyfshamhandembryonumbersofgoodintermediateandpoorprognosispatientssuggestspreviouslyunknownivfoutcomedeterminingfactorassociatedwithamh
AT kushnirvitalya definitionbyfshamhandembryonumbersofgoodintermediateandpoorprognosispatientssuggestspreviouslyunknownivfoutcomedeterminingfactorassociatedwithamh
AT senaritro definitionbyfshamhandembryonumbersofgoodintermediateandpoorprognosispatientssuggestspreviouslyunknownivfoutcomedeterminingfactorassociatedwithamh
AT darmonsarahk definitionbyfshamhandembryonumbersofgoodintermediateandpoorprognosispatientssuggestspreviouslyunknownivfoutcomedeterminingfactorassociatedwithamh
AT weghoferandrea definitionbyfshamhandembryonumbersofgoodintermediateandpoorprognosispatientssuggestspreviouslyunknownivfoutcomedeterminingfactorassociatedwithamh
AT wuyanguang definitionbyfshamhandembryonumbersofgoodintermediateandpoorprognosispatientssuggestspreviouslyunknownivfoutcomedeterminingfactorassociatedwithamh
AT wangqi definitionbyfshamhandembryonumbersofgoodintermediateandpoorprognosispatientssuggestspreviouslyunknownivfoutcomedeterminingfactorassociatedwithamh
AT zhanglin definitionbyfshamhandembryonumbersofgoodintermediateandpoorprognosispatientssuggestspreviouslyunknownivfoutcomedeterminingfactorassociatedwithamh
AT albertinidavidf definitionbyfshamhandembryonumbersofgoodintermediateandpoorprognosispatientssuggestspreviouslyunknownivfoutcomedeterminingfactorassociatedwithamh
AT baraddavidh definitionbyfshamhandembryonumbersofgoodintermediateandpoorprognosispatientssuggestspreviouslyunknownivfoutcomedeterminingfactorassociatedwithamh